Cambridge Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $974K | Sell |
3,427
-343
| -9% | -$100K | 0.04% | 140 |
|
|
2023
Q4 | $1.09M | Sell |
3,770
-511
| -12% | -$139K | 0.05% | 137 |
|
|
2023
Q3 | $1.15M | Buy |
4,281
+294
| +7% | +$73.4K | 0.05% | 132 |
|
|
2023
Q2 | $885K | Buy |
3,987
+2
| +0.1% | +$464 | 0.04% | 142 |
|
|
2023
Q1 | $963K | Buy |
3,985
+34
| +0.9% | +$8.35K | 0.05% | 140 |
|
|
2022
Q4 | $1.04M | Buy |
3,951
+86
| +2% | +$23.1K | 0.05% | 143 |
|
|
2022
Q3 | $871K | Sell |
3,865
-27
| -0.7% | -$6.54K | 0.04% | 149 |
|
|
2022
Q2 | $947K | Sell |
3,892
-469
| -11% | -$115K | 0.04% | 151 |
|
|
2022
Q1 | $1.05M | Sell |
4,361
-793
| -15% | -$182K | 0.04% | 161 |
|
|
2021
Q4 | $1.16M | Buy |
5,154
+947
| +23% | +$200K | 0.04% | 159 |
|
|
2021
Q3 | $895K | Buy |
4,207
+55
| +1% | +$12.7K | 0.03% | 140 |
|
|
2021
Q2 | $1.01M | Sell |
4,152
-135
| -3% | -$33.2K | 0.04% | 139 |
|
|
2021
Q1 | $1.07M | Buy |
4,287
+2,049
| +92% | +$489K | 0.04% | 132 |
|
|
2020
Q4 | $514K | Sell |
2,238
-120
| -5% | -$27.7K | 0.02% | 152 |
|
|
2020
Q3 | $600K | Sell |
2,358
-336
| -12% | -$83.2K | 0.03% | 146 |
|
|
2020
Q2 | $656K | Sell |
2,694
-167
| -6% | -$38.1K | 0.03% | 142 |
|
|
2020
Q1 | $580K | Sell |
2,861
-111
| -4% | -$24.2K | 0.04% | 146 |
|
|
2019
Q4 | $716K | Buy |
2,972
+262
| +10% | +$57.8K | 0.04% | 155 |
|
|
2019
Q3 | $524K | Buy |
2,710
+225
| +9% | +$43.2K | 0.03% | 167 |
|
|
2019
Q2 | $458K | Buy |
2,485
+156
| +7% | +$27.9K | 0.03% | 173 |
|
|
2019
Q1 | $442K | Sell |
2,329
-664
| -22% | -$127K | 0.03% | 176 |
|
|
2018
Q4 | $583K | Sell |
2,993
-521
| -15% | -$102K | 0.04% | 157 |
|
|
2018
Q3 | $729K | Sell |
3,514
-42
| -1% | -$8.28K | 0.04% | 153 |
|
|
2018
Q2 | $656K | Sell |
3,556
-163
| -4% | -$28.8K | 0.04% | 157 |
|
|
2018
Q1 | $634K | Sell |
3,719
-352
| -9% | -$64.6K | 0.04% | 165 |
|
|
2017
Q4 | $707K | Buy |
4,071
+148
| +4% | +$26.2K | 0.04% | 152 |
|
|
2017
Q3 | $732K | Buy |
3,923
+233
| +6% | +$41.3K | 0.05% | 146 |
|
|
2017
Q2 | $635K | Buy |
3,690
+29
| +0.8% | +$4.72K | 0.04% | 153 |
|
|
2017
Q1 | $601K | Sell |
3,661
-1,019
| -22% | -$169K | 0.04% | 170 |
|
|
2016
Q4 | $685K | Buy |
4,680
+709
| +18% | +$107K | 0.05% | 152 |
|
|
2016
Q3 | $663K | Sell |
3,971
-555
| -12% | -$93.9K | 0.05% | 151 |
|
|
2016
Q2 | $689K | Sell |
4,526
-335
| -7% | -$52.1K | 0.05% | 144 |
|
|
2016
Q1 | $729K | Sell |
4,861
-130
| -3% | -$19.3K | 0.06% | 131 |
|
|
2015
Q4 | $810K | Buy |
4,991
+255
| +5% | +$40.1K | 0.07% | 117 |
|
|
2015
Q3 | $655K | Buy |
4,736
+720
| +18% | +$113K | 0.06% | 128 |
|
|
2015
Q2 | $617K | Sell |
4,016
-55
| -1% | -$8.81K | 0.05% | 133 |
|
|
2015
Q1 | $651K | Buy |
4,071
+360
| +10% | +$56.7K | 0.05% | 133 |
|
|
2014
Q4 | $591K | Buy |
3,711
+210
| +6% | +$32.7K | 0.05% | 126 |
|
|
2014
Q3 | $492K | Buy |
3,501
+220
| +7% | +$28.7K | 0.04% | 135 |
|
|
2014
Q2 | $388K | Sell |
3,281
-200
| -6% | -$23.2K | 0.03% | 147 |
|
|
2014
Q1 | $429K | Buy |
3,481
+270
| +8% | +$32.7K | 0.04% | 139 |
|
|
2013
Q4 | $366K | Buy |
3,211
+1,140
| +55% | +$130K | 0.03% | 147 |
|
|
2013
Q3 | $232K | Buy |
+2,071
| New | +$225K | 0.02% | 168 |
|
Other funds holding AMGN
Cambridge Trust's AMGN Position: Q1 2024 in Review
Cambridge Trust reduced its Amgen (AMGN) stake by 9.1% in Q1 2024, selling an estimated $100K and leaving 3,427 shares worth $974K. The position accounts for 0.04% of the portfolio, ranked #140.
Cambridge Trust first reported a position in AMGN in Q3 2013 and has held it in 43 quarters since. The position peaked at $1.16M in Q4 2021. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Cambridge Trust held 3,427 shares of Amgen worth $974K as of Q1 2024.
- Cambridge Trust sold 343 Amgen shares in Q1 2024, an estimated $100K.
- Amgen made up 0.04% of Cambridge Trust's portfolio in Q1 2024, its #140 holding.
- Cambridge Trust first reported a position in Amgen in Q3 2013 and has held it in 43 quarters since.
- Cambridge Trust's Amgen position peaked at $1.16M in Q4 2021.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.